Results 121 to 130 of about 52,862 (295)

Alterations of bone proteins in medication‐related osteonecrosis of the jaw

European Journal of Oral Sciences, Volume 133, Issue 2, April 2025.
Abstract Changes in the protein expression pattern of osteoblastic lineage cells from the alveolar bone (OLAB) during medication‐related osteonecrosis of the jaw (MRONJ) have rarely been investigated. This lack of information is partly because of the limited availability of healthy samples and the lack of human alveolar bone cell lines for research ...
Andrea Schubert, Phillipp Brockmeyer, Philipp Kauffmann, Jan Wiegel, Florian Lautenbacher, Nicolai Miosge, Boris Schminke   +6 more
wiley   +1 more source

A 1H, 13C, 31P and 15N NMR study of (pyrrolidine-2,2-diyl)bisphosphonic acid, tetraalkyl(pyrrolidine-2,2-diyl)bisphosphonates and acyclic tetraethyl bisphosphonates

, 2000
peer reviewedA multinuclear magnetic resonance study (1H, 13C, 31P, 15N) was performed on a series of new cyclic pyrrolidine bisphosphonates and acyclic bisphosphonates. Values are reported and discussed for the chemical shifts and coupling constants of
Ziora, Z, Tseng, L., van Genderen, Marcel H P, Genderen, van, M.H.P., Jedrzejczyk, D, Olive, Gilles, Fischer, H., Raitza, M., Albert, K., Olive, G., Kafarski, P   +10 more
core   +1 more source

Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss [PDF]

, 2009
Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss (Bisphosphonates) will determine whether antiresorptive agents, in conjunction with the routine inflight exercise program, will protect ISS crewmembers from the regional decreases in ...
Shapiro, Jay, Evans, Harlan, Shackelford, Linda C., Jones, Jeffrey A., Sibonga, Jean, Koslovskaya, Inessa, Matsumoto, Toshio, Smith, Scott M., LeBlanc, Adrian, Spector, Elisabeth, Lang, Thomas F.   +10 more
core  

Treatment approaches for equine subchondral lucencies: Clinical considerations and therapeutic decision‐making

Equine Veterinary Education, EarlyView.
Summary Subchondral lucencies, also referred to as subchondral cystic lesions or osseous cyst‐like lesions, are radiographically identifiable defects of subchondral bone that remain an important cause of lameness and reduced athletic performance in horses.
C. Salazar‐Latorre, R. Salcedo‐Jiménez, M. Masri‐Daba   +2 more
wiley   +1 more source

The Impact of Brief‐Motivational Interviewing on Probing Depths, Recession, and Clinical Attachment Levels: A Randomized Clinical Trial With a 3‐Year Follow‐Up

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Aims The purpose of this study was to evaluate the impact of four brief‐motivational interviewing (MI) sessions compared to traditional oral hygiene instructions (OHI) during a 1‐year randomised clinical trial (RCT) with a 3‐year follow‐up post intervention.
Ligia E. Castillo‐Perez, Danna R. Paulson, Yvette G. Reibel, Michael D. Evans, Charles Seawell, Michelle C. Arnett   +5 more
wiley   +1 more source

Bisphosphonates and dental implants: current problems [PDF]

, 2009
Osteonecrosis of the jaw has been described in patients taking bisphosphonates after oral surgery procedures, including the placement of dental implants.
Flichy Fernández, Antonio, Peñarrocha Diago, Miguel, Balaguer Martínez, José, Bagán Sebastián, José Vicente   +3 more
core  

Ethylenediaminetetraacetic Acid and Other Dentine Bioactive Molecule‐Releasing Agents for Regenerative Endodontic Procedures: A Systematic Review

International Endodontic Journal, EarlyView.
ABSTRACT Background The bioactive molecules released from dentine are key to stem‐cell recruitment, proliferation and differentiation in regenerative endodontics. However, there is limited and conflicting information regarding current and potential agents for releasing dentine bioactive molecules for regenerative endodontic procedures.
Arwa Al‐Maswary, Xiaoxuan Deng, Haizal M. Hussaini, Lara T. Friedlander, Paul R. Cooper   +4 more
wiley   +1 more source

Chronic pruritus treated with alendronate in bilateral striopallidodentate calcinosis associated with an SLC20A2 gene mutation

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Adrien Boyard, Florian Stéphan, Boris Chaumette, Mathilde Moreau, Laure Bleton, Nicolas Hornez, Steeve Genestet, Jérémy Betrand, Amélie Bourhis, Morgane Le Bon‐Jégo, Thierry Bienvenu, Camille Verebi, Laurent Misery   +12 more
wiley   +1 more source

Denosumab discontinuation and fracture risk: getting the balance right

Internal Medicine Journal, EarlyView.
Abstract Denosumab is a highly effective therapy for osteoporosis. Since its approval by the Therapeutic Goods Administration (TGA) in 2010, use of denosumab has surged across Australia, delivering substantial fracture‐prevention benefits to tens of thousands of patients. However, stopping denosumab may lead to acute loss of bone with an increased risk
Albert S. Kim, Christian M. Girgis
wiley   +1 more source

Ostéonécrose des maxillaires et bisphosphonates

, 2005
Widely prescribed, bisphosphonates inhibit bone resorption. They are not metabolised and have long half-lives. Two cases of osteonecrosis of the jaws have recently been attributed to bisphosphonates at the University Hospital of Geneva.
Richter, Michel Willy, Vogt-Ferrier, Nicole Barbara, Junod, Alain, Carrel, Jean-Pierre   +3 more
core